#USA #Boston #diabetes management #Glytec #Hospital Solutions

Glytec's Remarkable Achievement in Hospital Diabetes Management

In a significant breakthrough for the healthcare sector, Glytec, a leader in cloud-based diabetes and insulin management Software-as-a-Service (SaaS), has marked a momentous year filled with noteworthy advances. This surge in performance comes at a time when hospitals are bracing for new Centers for Medicare & Medicaid Services (CMS) reporting requirements regarding inpatient diabetes management.

In 2024, Glytec witnessed substantial growth in its client portfolio, securing over 20 new and expanded client partnerships. As a result of these collaborations, hospitals using Glytec's technology achieved impressive outcomes. Specifically, they reported a 43% reduction in hypoglycemia rates, falling below the critical threshold of 70 mg/dL, and an astounding 88% reduction in severe hypoglycemia cases where blood glucose levels dropped below 40 mg/dL. Moreover, these achievements translated into significant cost savings, amounting to millions of dollars, thanks to the prevention of treatable hypoglycemia and enhancements in intensive care unit (ICU) throughput.

These benefits come at an essential juncture as hospitals prepare for new regulations. Starting fiscal year 2026, facilities must report instances of severe hypoglycemia and hyperglycemia alongside existing electronic clinical quality measures (eCQMs). Failure to comply could lead to reduced Medicare reimbursements—a pressing concern for many.

Patrick Cua, CEO of Glytec, expressed deep pride in their accomplishments in improving both healthcare outcomes and economic performance for their clients. He stated, “The increasing adoption of Glucommander as the industry standard for inpatient diabetes management positions Glytec for continued success in 2025 and further validates the trust of our clients and patients.”

The unique SaaS solution provided by Glytec successfully addresses a critical issue in the hospital sector: the management of insulin therapy. Statistics highlight that a staggering one-third of all hospitalized patients rely on insulin to manage high blood sugar, with more than 2 million patients annually experiencing adverse incidents linked to hypoglycemia. These episodes burden the healthcare system with costs exceeding $8 billion, yet notably, nearly one-third of hospitals lack glucose management metrics, and 59% do not employ automated systems for tracking hyperglycemia and hypoglycemia.

With over 350 clients, Glytec remains steadfast in its mission to enhance diabetes care while addressing the needs of numerous patients across the hospital landscape. The company's software is FDA-cleared and offers seamless integration with existing electronic medical records (EMR), facilitating smoother workflows and improved patient outcomes.

At its core, Glytec takes pride in being a mission-driven organization focused on enabling healthcare professionals and institutions to promote health equity and improve diabetes management from hospital settings right into the homes of patients. This innovative approach not only cultivates better clinical outcomes but also aims to extend life quality for individuals living with diabetes.

To learn more about Glytec and its transformative technologies, visit Glytec's website or follow them on LinkedIn for updates and insights into diabetes management advancements.